Ambrx Biopharma Inc. Increase (Decrease) in Accounts Payable
Ambrx Biopharma Inc. reported Increase (Decrease) in Accounts Payable of $3.15 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2023-08-09
- Ambrx Biopharma Inc. increase (decrease) in accounts payable for the quarter ending 2023-06-30 was -$732.00K, a 141.10% decline year-over-year.
- Ambrx Biopharma Inc. increase (decrease) in accounts payable for the quarter ending 2023-03-31 was $3.89M.
- Ambrx Biopharma Inc. increase (decrease) in accounts payable for the quarter ending 2022-06-30 was $1.78M.
- Ambrx Biopharma Inc. increase (decrease) in accounts payable for the quarter ending 2022-03-31 was -$920.00K.
- Ambrx Biopharma Inc. increase (decrease) in accounts payable for fiscal 2022 was -$1.83M, a 176.11% decline from fiscal 2021.
- Ambrx Biopharma Inc. increase (decrease) in accounts payable for fiscal 2021 was $2.40M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|
| 2023-06-30 | -$732.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $3.15M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $3.89M 10-Q · filed 2023-05-11 | ||
| 2022-12-31 | -$1.83M 10-K · filed 2023-03-30 | ||
| 2022-06-30 | $1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $861.00K 10-Q · filed 2023-08-09 | |
| 2022-03-31 | -$920.00K 10-Q · filed 2023-05-11 | ||
| 2021-12-31 | $2.40M 10-K · filed 2023-03-30 | ||
| 2021-06-30 | $655.00K 6-K · filed 2022-08-29 | ||
| 2020-12-31 | -$3.25M 20-F · filed 2022-04-26 | ||
| 2019-12-31 | $3.78M 20-F · filed 2022-04-26 |